CIK 0001684144
- Non-accelerated filer
- Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- Operating
- Phone
- +1 734-369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-10 | Williams Rodney James Director | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2019-01-10 | Solensky Gerald JR President and CEO | Grant or award · Stock Option (right to buy) | +2,100,000 | 2,100,000 | ||
| 2019-01-10 | Rowe Jeffrey M Director | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2019-01-10 | Shameze Rampertab Chief Financial Officer | Grant or award · Stock Option (right to buy) | +950,000 | 950,000 | ||
| 2019-01-10 | Morley Stephanie COO & VP of Product Dev | Grant or award · Stock Option (right to buy) | +900,000 | 900,000 | ||
| 2019-01-10 | Herbst Bruk Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-12-20 | Williams Rodney James Director | Exercise or conversion | +26,900 | $1.20 | $32K | 161,900 |
| 2018-12-20 | Williams Rodney James Director | Exercise or conversion · Stock Option (right to buy) | −26,900 | 0 | ||
| 2018-11-29 | Rowe Jeffrey M Director | Exercise or conversion | +175,000 | $1.20 | $210K | 275,000 |
| 2018-11-29 | Rowe Jeffrey M Director | Exercise or conversion · Stock Option (right to buy) | −175,000 | 0 | ||
| 2018-10-11 | Solensky Gerald JR President and CEO | Exercise or conversion | +200,000 | $1.20 | $240K | 38,151,100 |
| 2018-10-11 | Solensky Gerald JR President and CEO | Exercise or conversion · Stock Option (right to buy) | −200,000 | 0 | ||
| 2018-10-02 | Solensky Gerald JR President and CEO | Sale | −164 | $1.89 | $310 | 37,950,936 |
| 2018-08-28 | LeBar James Director | Sale | −200,000 | $2.15 | $430K | 20,000 |
| 2018-06-11 | Williams Rodney James Director | Sale | −1,000 | $1.92 | $2K | 135,000 |
| 2018-06-01 | Williams Rodney James Director | Sale | −500 | $1.93 | $965 | 136,000 |
| 2018-05-31 | Williams Rodney James Director | Sale | −1,500 | $1.91 | $3K | 136,500 |
| 2018-05-24 | Williams Rodney James Director | Sale | −500 | $1.92 | $960 | 138,000 |
| 2018-05-23 | Williams Rodney James Director | Sale | −400 | $1.92 | $768 | 138,600 |
| 2018-05-23 | Williams Rodney James Director | Sale | −88 | $1.91 | $168 | 138,512 |
Page 12 of 14 · 264 trades